U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 202514

Marketing Status: Prescription
Active Ingredient: TAFLUPROST
Proprietary Name: ZIOPTAN
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 0.0015%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AT
Application Number: N202514
Product Number: 001
Approval Date: Feb 10, 2012
Applicant Holder Full Name: THEA PHARMA INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top